1234616-19-3 Usage
Uses
Used in Pharmaceutical Industry:
(5-bromo-3-fluoropyridin-2-yl)methanamine is used as a building block or intermediate for the synthesis of various pharmaceuticals. Its unique structure and functional groups make it a valuable component in the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, (5-bromo-3-fluoropyridin-2-yl)methanamine is utilized as a key intermediate in the production of agrochemicals. Its incorporation into these compounds can contribute to the development of more effective and targeted pest control solutions.
Used in Fine Chemicals Production:
(5-bromo-3-fluoropyridin-2-yl)methanamine is also used in the production of fine chemicals, which are high-purity chemicals used in various applications, including the synthesis of specialty materials and the development of advanced technologies.
Used in Research and Development:
(5-bromo-3-fluoropyridin-2-yl)methanamine serves as an important research material in the scientific community. Its potential biological activities and pharmacological properties make it a subject of interest for further study and exploration, with the aim of discovering new applications and enhancing existing ones.
Check Digit Verification of cas no
The CAS Registry Mumber 1234616-19-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,4,6,1 and 6 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1234616-19:
(9*1)+(8*2)+(7*3)+(6*4)+(5*6)+(4*1)+(3*6)+(2*1)+(1*9)=133
133 % 10 = 3
So 1234616-19-3 is a valid CAS Registry Number.
1234616-19-3Relevant academic research and scientific papers
IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS
-
, (2020/08/05)
The invention provides compounds of formula (I): or a pharmaceutically-acceptable salt thereof, wherein the variables are defined in the specification, that are inhibitors of JAK kinases, particularly JAK3. The invention also provides pharmaceutical compo
